Showing results (1231-1240 of 1,247) with videos related to
Sort By:
Pageof 125
Frontiers in Plant Science|June 30, 2017
Morphological Plant Modeling: Unleashing Geometric and Topological Potential within the Plant SciencesAlexander Bucksch, Acheampong Atta-Boateng, Akomian F Azihou, et al.Annals of Pediatric Cardiology|September 14, 2019
Indian guidelines for indications and timing of intervention for common congenital heart diseases: Revised and updated consensus statement of the Working group on management of congenital heart diseasesAnita Saxena, Jay Relan, Ravi Agarwal, et al.JACC. Cardiovascular Interventions|March 1, 2023
Coronary Obstruction From TAVR in Native Aortic Stenosis: Development and Validation of Multivariate Prediction ModelJaffar M Khan, Norihiko Kamioka, John C Lisko, et al.Indian Pediatrics|February 16, 2020
Indian Guidelines for Indications and Timing of Intervention for Common Congenital Heart Diseases: Revised and Updated Consensus Statement of the Working Group on Management of Congenital Heart Diseases. Abridged Secondary PublicationAnita Saxena, Jay Relan, Ravi Agarwal, et al.Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.Public Health Action|March 18, 2026
Does active case finding detect TB early in programme settings? A national-level study in IndiaH D Shewade, S Kiran Pradeep, P Ravichandran, et al.Science Translational Medicine|December 1, 2022
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge 1 year laterEmma C Milligan, Katherine Olstad, Caitlin A Williams, et al.Indian Heart Journal|September 24, 2019
Guidelines for the management of common congenital heart diseases in India: A consensus statement on indications and timing of interventionAnita Saxena, Jay Relan, Ravi Agarwal, et al.Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assayMichael J Peluso, Saki Takahashi, Jill Hakim, et al.Journal of Medicinal Chemistry|May 26, 2012
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBrian S Safina, Stewart Baker, Matt Baumgardner, et al.Pageof 125